Image
26.05.2023
50% of people living with diabetes have missed healthcare appointments...
Over 50% of people living with diabetes miss healthcare appointments at least sometimes due to stigma, ac...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more